MedTrace Logo

Zilver PTX Delivery System

NCT02271529 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-02-26

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

Zilver® PTX® Drug-Eluting Peripheral Stent

Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Andrew Holden, MD · Auckland District Health Board

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Australia
  • Germany
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271529 on ClinicalTrials.gov